Drugs / Ginkgo diterpene lactone meglumine injection
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05663307 Comparator | Jan 2021 → Nov 2023 | ischemic stroke | Shanghai Yueyang Integrated Medicine Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ginkgo diterpene lactone meglumine injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05663307 ↗ |
| Route | Intravenous | “Intravenous injections of Ginkgo diterpene lactone meglumine injection at a dose of 25 mg (5ml) diluted with 250 ml physiological saline for 14 days” NCT05663307 ↗ |